期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

卵巢交界性肿瘤80例临床分析 被引量：1

下载PDF
导出
摘要 卵巢交界性肿瘤（borderline ovarian tumor，SOT）是一种处于良、恶性交界范畴内的肿瘤，与同样分期的卵巢癌相比预后好得多。BOT发病率占卵巢恶性肿瘤的4％-14％。以往BOT的治疗方式和卵巢癌相同，但是近十几年来随着对BOT认识的不断加深，其治疗方式发生了巨大变化，对于年轻的有生育要求的患者，多采取保守性手术。本文总结80例BOT的临床资料，分析如下。
作者 马耀梅 田爱军 张景玉
机构地区 天津市中心妇产科医院 新疆兵团建工师卡子湾医院 新疆石河子大学医学院
出处 《天津医科大学学报》 2009年第2期326-328,共3页 Journal of Tianjin Medical University
关键词 卵巢交界性肿瘤 低度恶性潜能 卵巢癌
分类号 R737.31 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Maltaris T,Boehm D,Dittrich R,et al.Reproduction beyond cancer:A message of hope for young women[J].Gynecol Oncol,2006,103(3):1109.
  • 2王晓莉,石钢,梁家智,王世阆.CA_(125)、CA_(19.9)、CEA在卵巢上皮性交界性肿瘤中的临床价值[J].现代妇产科进展,2001,10(5):343-345. 被引量：2
  • 3Cadron I,Leunen K,Van Grop T,et al.Management of borderline ovarian neoplasms[J].J Clin Oncol,2007,25(20):2928.
  • 4Suh-Burgmann.Long-term outcomes following conservative surgery for bordline tumor of the ovary:a large population-based study[J].Gynecol Oncol,2006,103(3):841.
  • 5Donnez J,Munschke A,Berliere M,et al.Safety of conservative management and fertility outcome in women with borderline tumors of the ovary[J].Fertil Steril,2003,79(5):1216.
  • 6Morice P,Camatte S,Wicart-Poque F,et al.Results of conservative management of epithelial malignant and borderline ovarian tumours[J].Hum Reprod Update,2003,9(1):185.
  • 7Leys D.Neurological protection provided by candesartan:reviewing the latest study results[J].Curr Med Res Opin,2003,19(5):445.
  • 8Morice P,Camatte S,Rey A,et al.Prognostic factors for patients with advanced stage serous borderline tumours of the ovary[J].Ann Oncol,2003,14(2):592.
  • 9王世阆,孙维纲,张国楠.卵巢上皮性交界性肿瘤[J].现代妇产科进展,2006,15(5):321-327. 被引量：2
  • 10段微,范逢晓.保留生育功能手术对卵巢交界性肿瘤临床治疗效果的影响[J].中国实用妇科与产科杂志,2006,22(6):449-450. 被引量：11

二级参考文献17

  • 1连利娟.林巧稚妇科肿瘤学[M].人民卫生出版社,1996.306-312.
  • 2Gershenson DM.Clinical management potential tumors of low malignancy[J].Best Pract Res Clin Obstet Gynaecol,2002,16(4):513-527.
  • 3International Federation of Gynecology and Obstetrics.Changes in definitions of clinical staging for carcinoma of the cervix and ovary[J].Am J Obstet Gynecol,1987,156:263-264.
  • 4Gotlieb WH,Flikker S,Davidson B,et al.Borderline tumors of the ovary:fertility treatment,conservative management,and pregnancy outcome[J].Cancer,1998,82:141-146.
  • 5Morris RT,Gershenson DM,Silva EG,et al.Outcome and reproductive function after conservative surgery for borderline ovarian tumors[J].Obstet Gynecol,2000,95:541-547.
  • 6Boran N,Cil BA,Tulunay G,et al.Fertility and recurrence results of conservative surgery for borderline ovarian tumors[J].Gynecol Oncol,2005,97:845-851.
  • 7Fauvet R,Boccara J,Dufournet C,et al.Restaging surgery for women with borderline ovarian tumors[J].Cancer,2004,100:1145-1151.
  • 8Camatte S,Morice P,Thoury A,et al.Impact of surgical staging in patients with macroscopic "stage Ⅰ" ovarian borderline tumors:analysis of a continuous serious of 101 cases[J].Eur J Cancer,2004,40(12):1842-1849.
  • 9NIH Consensus Development Panel on Ovarian Cancer.Ovarian cancer:screening,treatment and follow-up[J].JAMA,1995,273:491-497.
  • 10Morice P,Camatte S,Hassan JE,et al.Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors[J].Fertile Steril,2001,75(1):92-96.

共引文献11

同被引文献10

  • 1Taylor HC. Malignant and semimalignant tumors of the ovary[ J]. Surg Gyrtecol Obstet , 1929,48 : 204 - 230.
  • 2Jones MB. Borderline ovarian tumors: current concepts for prognos- tic factors and clinical management [ J ]. Clin Obstet Gynecol, 2006,49:517 - 525.
  • 3Neeraj Lalwanil, Alampady K. P. Shanbhoguel, Current Update on Borderline Ovarian Neoplasms [ J ]. AJR: 194, February 2010 : 330 336.
  • 4Tinelli R ,Tinelli A, Tinelli FG, et al. Conserve surgery for border- line ovarian tumors : a review [ J ]. Gynecoloncol, 2006,1 O0 : 185 - 191.
  • 5Ren J, Peng Z, Yang K. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors[ J]. Gynecol On- col,2008,110:162 - 167.
  • 6Zanetta G, RotaS, Chiaris,et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to in- vasive carcinoma: A prospective study[ J ]. J Clin Oncol,2001,19 : 2658 - 2664.
  • 7Mofice P, Camatte S, Rey A, et al. Prognostic factors for patients with advanced stage serous borderline tumours of the ovary [ J ]. Ann Onco1,2003 ,14 :592 - 598.
  • 8Crispens MA, Bodurka D, Deavers M ,et al. Response and survival in patients with Progressive or Recurrent serous ovarian tumors of low malignant Potential[ J ]. Obstet Gyneco1,2002,99:3 - 10.
  • 9魏静,李小平,唐军,王建六,耿京,赵彦,崔恒,魏丽惠.卵巢交界性肿瘤47例临床分析[J].中国妇产科临床杂志,2010,11(5):346-348. 被引量：7
  • 10温灏,吴小华.卵巢交界性肿瘤的治疗进展[J].中华妇产科杂志,2010,45(12):943-945. 被引量：7

引证文献1

天津医科大学学报
2009年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部